Sujha Subramanian1, Donatus U Ekwueme2, Jacqueline W Miller2, Jaya S Khushalani2, Justin G Trogdon3, Faye L Wong2. 1. RTI International, 307 Waverley Oaks Road, Waltham, MA, 02452, USA. ssubramanian@rti.org. 2. Division of Cancer Prevention and Control, Centers for Disease Control and Prevention, GA, Atlanta, USA. 3. Department of Health Policy and Management, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, USA.
Abstract
OBJECTIVES: To estimate awardee-specific costs of delivering breast and cervical cancer screening services in their jurisdiction and to assess potential variation in the cost of key activities across awardees. METHODS: We developed the cost assessment tool to collect resource use and cost data from the National Breast and Cervical Cancer Early Detection Program awardees for 3 years between 2006 and 2010 and generated activity-based cost estimates. We estimated awardee-specific cost per woman served for all activities, clinical screening delivery services, screening promotion interventions, and overarching program support activities. RESULTS: The total cost per woman served by the awardees varied greatly from $205 (10th percentile) to $499 (90th percentile). Differences in the average (median) cost per person served for clinical services, health promotion interventions, and overarching support activities ranged from $51 to $125. CONCLUSIONS: The cost per woman served varied across awardee and likely reflected underlying differences across awardees in terms of screening infrastructure, population served, and barriers to screening uptake. Collecting information on contextual factors at the awardee, health system, provider, and individual levels may assist in understanding this variation in cost.
OBJECTIVES: To estimate awardee-specific costs of delivering breast and cervical cancer screening services in their jurisdiction and to assess potential variation in the cost of key activities across awardees. METHODS: We developed the cost assessment tool to collect resource use and cost data from the National Breast and Cervical Cancer Early Detection Program awardees for 3 years between 2006 and 2010 and generated activity-based cost estimates. We estimated awardee-specific cost per woman served for all activities, clinical screening delivery services, screening promotion interventions, and overarching program support activities. RESULTS: The total cost per woman served by the awardees varied greatly from $205 (10th percentile) to $499 (90th percentile). Differences in the average (median) cost per person served for clinical services, health promotion interventions, and overarching support activities ranged from $51 to $125. CONCLUSIONS: The cost per woman served varied across awardee and likely reflected underlying differences across awardees in terms of screening infrastructure, population served, and barriers to screening uptake. Collecting information on contextual factors at the awardee, health system, provider, and individual levels may assist in understanding this variation in cost.
Entities:
Keywords:
Breast cancer screening; Cervical cancer screening; Program cost
Authors: Sujha Subramanian; Florence K L Tangka; Donatus U Ekwueme; Justin Trogdon; Wesley Crouse; Janet Royalty Journal: Cancer Causes Control Date: 2015-04-04 Impact factor: 2.506
Authors: Heidi D Nelson; Miranda Pappas; Amy Cantor; Jessica Griffin; Monica Daeges; Linda Humphrey Journal: Ann Intern Med Date: 2016-01-12 Impact factor: 25.391
Authors: Donatus U Ekwueme; Sujha Subramanian; Justin G Trogdon; Jacqueline W Miller; Janet E Royalty; Chunyu Li; Gery P Guy; Wesley Crouse; Hope Thompson; James G Gardner Journal: Cancer Date: 2014-08-15 Impact factor: 6.860
Authors: Donatus U Ekwueme; James G Gardner; Sujha Subramanian; Florence K Tangka; Bela Bapat; Lisa C Richardson Journal: Cancer Date: 2008-02-01 Impact factor: 6.860
Authors: Evan R Myers; Patricia Moorman; Jennifer M Gierisch; Laura J Havrilesky; Lars J Grimm; Sujata Ghate; Brittany Davidson; Ranee Chatterjee Mongtomery; Matthew J Crowley; Douglas C McCrory; Amy Kendrick; Gillian D Sanders Journal: JAMA Date: 2015-10-20 Impact factor: 56.272